Announcements Trials

Browse Landscape

Status

Completed 3 Unknown 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 24 Thoracic 8 Genitourinary 7 Gynecologic 6 Breast 6 Lymphoid 5 Head & Neck 5 Sarcoma 4 Dermatologic 4 CNS 4 Tumor-Agnostic 3 Other hematologic neoplasm 3 Other solid neoplasm 2 Other 2 Plasma cell 1 Myeloid 1 Endocrine 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 98 daratumumab 57 Lenalidomide 53 Bortezomib 38 pomalidomide 37 Cyclophosphamide 37 carfilzomib 25 Calcium Dobesilate 25 fludarabine 22 talquetamab 19 iberdomide 18 isatuximab 17 Specimen Handling 17 Magnetic Resonance Spectroscopy 17 Biopsy 15 selinexor 13 dexamethasone acetate 12 belantamab mafodotin 12 Melphalan 12 dexamethasone 21-phosphate 11 auricularum 10 venetoclax 8 fludarabine phosphate 7 elotuzumab 7 X-Rays 6 tocilizumab 5 Blood Specimen Collection 5 ruxolitinib 4 ixazomib 4 Trimethoprim, Sulfamethoxazole Drug Combination 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Observation × Plasma cell × Clear all

NCT05001087 2025-02-27

MY MYELOMA

Fondazione EMN Italy Onlus

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡